CD8A and neoplasm: Furthermore, the administration of LY364947 to LLC1‐bearing mice during the dark phase led to a redistribution of CD8+ T cells, dispersing them from CAF‐dense regions to a more widespread distribution throughout the tumor tissues (Figure 4C).